Tech Company Financing Transactions

Bicycle Therapeutics Funding Round

Bicycle Therapeutics secured a $51.4 million Series B financing round on 6/2/2017. Backers included Vertex Venture Capital, Atlas Accelerator and Cambridge Innovation Capital.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

4 Hartwell Pl.
Lexington, MA 02421
USA

Phone

Undisclosed

Website

www.bicycletherapeutics.com

Email Address

[email protected]

Overview

Bicycle Therapeutics is developing a new class of medicines to treat oncology and other important diseases based on its proprietary bicyclic peptide (Bicycle) product platform. Bicycles exhibit the affinity and exquisite target specificity usually associated with antibodies.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Kevin Lee

        

Chief Financial Officer

Lee Kalowski

        

Chief Scientific Officer

Nick Keen

        

VP - Operations

Michael Skynner

        

Browse more venture capital transactions:

Prev: 6/2/2017: Bright Health venture capital transaction
Next: 6/2/2017: Arcadia venture capital transaction

Share this article

Where The Data Comes From

We do our best to report on every notable VC transaction. VC investment data records reported here come from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary